Financials
- Market Capitalization 220.29 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.53
売上高対価格比率
8.08
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3451 | KROS Keros Therapeutics, Inc. - common stock | 11.61 USD | -2.85% | +0.43% | +4.59% | -23.11% | 230.19 M USD | ||
| 3469 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.78 USD | +0.72% | +3.73% | +6.11% | -4.79% | 223.99 M USD | ||
| 3479 | STRO Sutro Biopharma, Inc. - Common Stock | 13.28 USD | -6.94% | -12.29% | -22.29% | -23.63% | 220.20 M USD | ||
| 3494 | TRDA Entrada Therapeutics, Inc. - Common Stock | 5.50 USD | -3.00% | -0.36% | -19.12% | -21.09% | 214.15 M USD |